🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
29% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5.5 Kcal
Total Fat
498 mg
Protein
158 mg
Carbohydrates
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 280mg UL 3000mg
Gamma-Linolenic Acid
9 mg
1 mg TE (8.4% DV)
✅ Within RDA (0.1× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 1mg UL 1000mg

Other Ingredients

Capsule Shell Ethyl-EPA Concentrate organic cold-pressed virgin Evening Primrose Oil Vitamin E

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions for use For general wellbeing: adults and children aged twelve years and over should take 2 glucosamine & Calcium capsules (blue blister) and 1 E-EPA 70 capsule (silver blister) daily For individuals who are especially active or those who require additional joint & bone support in later life: take 4 glucosamine & Calcium capsules (blue blister) and 2 E-EPA 70 capsules (silver blister) daily Take Omegaflex Duo with food for optimum absorption.

⚠️ Warnings & Precautions

It is not advisable to exceed the above dose unless advised by a healthcare practitioner.

If taking any medication, seek professional medical advice before taking this product. If you are taking any mediation that thins the blood, do not take this product without prior medical advice.

This product should not be used as a substitute for a balanced diet.

Store in a cool, dry place away from direct sunlight and away from children.

🧪 Formulation Notes

Advanced multi-action joint & bone support

Marine Ethyl-EPA 70% with plant GLA Source of beneficial fatty acids & phytonutrients

Contains no artificial colours, flavours or preservatives.

Omegaflex Duo combines highly bioavailable glucosamine hydrochloride, calcium and other trace minerals derived from the marine Algas Calcareas with 70% ethyl-EPA concentrated from marine anchovy oil, and GLA and triterpenes from organic virgin evening primrose oil.

Ethyl-EPA derived from sustainable marine anchovies anchovies and certified free from PCBs, mercury & dioxins

Free from: dairy, gluten, lactose, shellfish, yeast Non-GMO

Not tested on animals

Additional Information

Replenish & protect

Store in a cool, dry place away from direct sunlight and away from children.

Supplementation may be helpful to correct nutrient deficiencies though it can never be a substitute for a healthy diet and active lifestyle, which play a crucial role in maintaining overall wellbeing.

Product Details

DSLD Entry Date 2021-07-27
Product Type Other Combinations
Form Capsule
Bundle Omegaflex Duo
DSLD ID 249520
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →